Overview
- Editors:
-
-
Oussama Abla
-
University of Toronto, The Hospital for Sick Children, Toronto, Canada
-
Gritta Janka
-
Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
First comprehensive book on histiocytic disorders in over ten years
Features the most recent advances and treatment strategies for common and uncommon histiocytic disorders
Written by international experts in the field
Includes supplementary material: sn.pub/extras
Access this book
Other ways to access
Table of contents (21 chapters)
-
-
Pathology of Histiocytic Disorders
-
-
- Jennifer Picarsic, Ronald Jaffe
Pages 3-50
-
Langerhans Cell Histiocytosis (LCH)
-
-
-
- Etai Adam, Rima Jubran, Sheila Weitzman
Pages 73-85
-
- Milen Minkov, Jennifer Picarsic, Karoly Lakatos
Pages 87-101
-
- Carlos Rodriguez-Galindo, Cor van den Bos
Pages 103-118
-
- Oussama Abla, Carlos Rodriguez-Galindo, Paul Veys
Pages 119-137
-
- Michael Girschikofsky, Abdellatif Tazi
Pages 139-153
-
- Vasanta Nanduri, Lilibeth R. Torno, Riccardo Haupt
Pages 155-170
-
Hemophagocytic Lymphohistiocytosis (HLH)
-
Front Matter
Pages 171-171
-
- J. Pachlopnik Schmid, Benjamin Volkmer, Stephan Ehl
Pages 173-187
-
- AnnaCarin Horne, Karin Beutel
Pages 189-196
-
- Geneviève de Saint Basile, Despina Moshous, Alain Fischer
Pages 197-214
-
- Kai Lehmberg, Fumihiro Ochi, Kim E. Nichols, Eiichi Ishii
Pages 215-231
-
- Alexei A. Grom, AnnaCarin Horne, Fabrizio De Benedetti
Pages 233-246
-
- Jan-Inge Henter, Rebecca A Marsh, Tatiana von Bahr Greenwood
Pages 247-263
-
- K. Scott Baker, Michael B. Jordan
Pages 265-274
-
- Paul La Rosée, Rafal Machowicz
Pages 275-290
About this book
This volume provides a comprehensive and world-class review of the field of histiocytic neoplasms and hemophagocytic lymphohistiocytosis (HLH). It reviews all the advances in the field of histiocytoses during the last ten years, particularly with regards to the genomic findings in LCH and other histiocytic neoplasms and the new suggested classification of the histiocytic disorders. Additionally, it features a state-of-the art update on the most recent treatment strategies for LCH, including the results of the last LCH-III international trial, salvage therapies such as reduced-intensity conditioning (RIC) stem cell transplant (SCT), and targeted therapies with BRAF and MEK inhibitors, as well as the challenging cases of CNS-neurodegenerative LCH and its therapeutic perspectives. For primary and secondary HLH the book updates the most recent genetic and pathophysiological findings, including macrophage-activation syndrome (MAS), and includes a special chapter on HLH in adults. Treatment chapters encompass therapy for newly diagnosed HLH and refractory disease as well as stem-cell transplantation and novel therapies. The text also highlights the most recent advances in the treatment of the uncommon histiocytic disorders, such as Erdheim-Chester disease (ECD), Juvenile xanthogranuloma (JXG) and JXG-like conditions, Rosai-Dorfman disease (RDD), and the very rare malignant histiocytoses.
Written by international experts in the field, Histiocytic Disorders is a valuable resource for clinicians, researchers, fellows and residents who are interested in or manage histiocytic disorders in children and adults.
Editors and Affiliations
-
University of Toronto, The Hospital for Sick Children, Toronto, Canada
Oussama Abla
-
Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Gritta Janka
About the editors
Oussama Abla, MD
Chair, Rare Histiocytoses Steering Committee- Histiocyte Society, Associate Professor of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario,Â
Canada
Gritta Janka, MD, PhD
Chair, HLH Steering Committee, Histiocyte Society, Professor emeritus of Pediatrics, University Medical Center Hamburg Eppendorf, Pediatric Hematology and Oncology, Hamburg, Germany